Pyrimidyl cyclopentanes as akt protein kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/10 (2006.01) A61K 31/438 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01) C07D 487/10 (2006.01)

Patent

CA 2714888

The present invention provides compounds of Formula (I) including tautomers, resolved enantiomers, resolved diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as Akt protein kinase inhibitors and for the treatment of Akt-mediated diseases, for example, hyperproliferative diseases such as cancer.

L'invention concerne des composés de formule (I) y compris les tautomères, énantiomères résolus, diastéréoisomères résolus, solvates, métabolites, sels et promédicaments pharmaceutiquement acceptables de ceux-ci. Il est également proposé des procédés d'utilisation des composés de la présente invention en tant qu'inhibiteurs de protéine kinase Akt pour le traitement de maladies véhiculées par Akt, par exemple des maladies hyperprolifératives telles que le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrimidyl cyclopentanes as akt protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidyl cyclopentanes as akt protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidyl cyclopentanes as akt protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1407243

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.